(FORM) FormFactor - Ratings and Ratios
Probe Cards, Analytical Probes, Probe Stations, Thermal Systems, Cryogenic
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 56.0% |
| Value at Risk 5%th | 80.6% |
| Relative Tail Risk | -12.53% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.62 |
| Alpha | 6.60 |
| CAGR/Max DD | 0.62 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.406 |
| Beta | 1.946 |
| Beta Downside | 1.239 |
| Drawdowns 3y | |
|---|---|
| Max DD | 62.75% |
| Mean DD | 20.57% |
| Median DD | 12.78% |
Description: FORM FormFactor November 10, 2025
FormFactor, Inc. (NASDAQ: FORM) designs, manufactures, and sells a suite of semiconductor test hardware-including probe cards, analytical probes, probe stations, thermal and cryogenic systems-and provides related services such as on-site maintenance, training, and technical support. Its probe cards target a broad range of device categories, from system-on-chip and mobile processors to DRAM, NAND, and emerging quantum-computer processors, while its analytical probes support device characterization, failure analysis, and prototype debugging.
In FY 2023 the company reported revenue of roughly $1.2 billion, representing a 12 % year-over-year increase driven primarily by higher demand for AI-accelerator and 5G-related test solutions. Gross margins hovered around 38 %, and operating cash flow exceeded $200 million, giving FormFactor a solid liquidity position despite the capital-intensive nature of its equipment business.
The semiconductor test equipment market is currently being propelled by two macro trends: (1) the rapid scaling of advanced-node chips for artificial-intelligence workloads, which raises the need for higher-precision, higher-throughput probe solutions; and (2) the resurgence of legacy-node production for automotive and IoT devices, sustaining demand for a diversified product mix. FormFactor’s exposure to both high-growth (AI) and stable (automotive/IoT) segments helps mitigate the cyclical risk inherent in semiconductor capital spending.
For a deeper, data-driven view of FormFactor’s valuation and risk profile, you may find the analyst tools on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (39.7m TTM) > 0 and > 6% of Revenue (6% = 45.6m TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA -3.90pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 56.52% (prev 65.42%; Δ -8.90pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 105.3m > Net Income 39.7m (YES >=105%, WARN >=100%) |
| Net Debt (-64.5m) to EBITDA (116.4m) ratio: -0.55 <= 3.0 (WARN <= 3.5) |
| Current Ratio 4.30 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (77.7m) change vs 12m ago -0.90% (target <= -2.0% for YES) |
| Gross Margin 38.41% (prev 40.72%; Δ -2.31pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 64.44% (prev 64.33%; Δ 0.10pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 190.1 (EBITDA TTM 116.4m / Interest Expense TTM 418.0k) >= 6 (WARN >= 3) |
Altman Z'' 4.03
| (A) 0.36 = (Total Current Assets 559.3m - Total Current Liabilities 130.1m) / Total Assets 1.20b |
| (B) 0.13 = Retained Earnings (Balance) 152.1m / Total Assets 1.20b |
| (C) 0.07 = EBIT TTM 79.5m / Avg Total Assets 1.18b |
| (D) 0.79 = Book Value of Equity 152.2m / Total Liabilities 193.4m |
| Total Rating: 4.03 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 46.28
| 1. Piotroski 4.50pt |
| 2. FCF Yield 0.12% |
| 3. FCF Margin 0.70% |
| 4. Debt/Equity 0.03 |
| 5. Debt/Ebitda -0.55 |
| 6. ROIC - WACC (= -7.40)% |
| 7. RoE 4.06% |
| 8. Rev. Trend 6.49% |
| 9. EPS Trend -0.54% |
What is the price of FORM shares?
Over the past week, the price has changed by +2.76%, over one month by +13.00%, over three months by +61.71% and over the past year by +34.24%.
Is FORM a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 6
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the FORM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 56.9 | -0.2% |
| Analysts Target Price | 56.9 | -0.2% |
| ValueRay Target Price | 58.1 | 2.1% |
FORM Fundamental Data Overview December 11, 2025
P/E Trailing = 109.9623
P/E Forward = 40.3226
P/S = 5.9497
P/B = 4.4816
P/EG = 0.71
Beta = 1.12
Revenue TTM = 759.3m USD
EBIT TTM = 79.5m USD
EBITDA TTM = 116.4m USD
Long Term Debt = 11.4m USD (from longTermDebt, last quarter)
Short Term Debt = 8.53m USD (from shortTermDebt, last quarter)
Debt = 33.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -64.5m USD (from netDebt column, last quarter)
Enterprise Value = 4.28b USD (4.52b + Debt 33.2m - CCE 266.0m)
Interest Coverage Ratio = 190.1 (Ebit TTM 79.5m / Interest Expense TTM 418.0k)
FCF Yield = 0.12% (FCF TTM 5.33m / Enterprise Value 4.28b)
FCF Margin = 0.70% (FCF TTM 5.33m / Revenue TTM 759.3m)
Net Margin = 5.23% (Net Income TTM 39.7m / Revenue TTM 759.3m)
Gross Margin = 38.41% ((Revenue TTM 759.3m - Cost of Revenue TTM 467.6m) / Revenue TTM)
Gross Margin QoQ = 39.78% (prev 37.25%)
Tobins Q-Ratio = 3.56 (Enterprise Value 4.28b / Total Assets 1.20b)
Interest Expense / Debt = 1.26% (Interest Expense 418.0k / Debt 33.2m)
Taxrate = 29.07% (5.94m / 20.4m)
NOPAT = 56.4m (EBIT 79.5m * (1 - 29.07%))
Current Ratio = 4.30 (Total Current Assets 559.3m / Total Current Liabilities 130.1m)
Debt / Equity = 0.03 (Debt 33.2m / totalStockholderEquity, last quarter 1.01b)
Debt / EBITDA = -0.55 (Net Debt -64.5m / EBITDA 116.4m)
Debt / FCF = -12.10 (Net Debt -64.5m / FCF TTM 5.33m)
Total Stockholder Equity = 978.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.30% (Net Income 39.7m / Total Assets 1.20b)
RoE = 4.06% (Net Income TTM 39.7m / Total Stockholder Equity 978.3m)
RoCE = 8.03% (EBIT 79.5m / Capital Employed (Equity 978.3m + L.T.Debt 11.4m))
RoIC = 5.69% (NOPAT 56.4m / Invested Capital 991.2m)
WACC = 13.09% (E(4.52b)/V(4.55b) * Re(13.18%) + D(33.2m)/V(4.55b) * Rd(1.26%) * (1-Tc(0.29)))
Discount Rate = 13.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.43%
[DCF Debug] Terminal Value 52.77% ; FCFE base≈23.3m ; Y1≈16.2m ; Y5≈8.27m
Fair Price DCF = 1.10 (DCF Value 85.3m / Shares Outstanding 77.5m; 5y FCF grow -35.81% → 3.0% )
EPS Correlation: -0.54 | EPS CAGR: -7.38% | SUE: 2.35 | # QB: 1
Revenue Correlation: 6.49 | Revenue CAGR: -0.30% | SUE: 1.06 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.31 | Chg30d=+0.037 | Revisions Net=+2 | Analysts=6
EPS next Year (2026-12-31): EPS=1.55 | Chg30d=+0.219 | Revisions Net=+4 | Growth EPS=+31.5% | Growth Revenue=+9.8%
Additional Sources for FORM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle